Related Experiment Videos
Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption
T Inui1, O Ishibashi, T Inaoka
1International Research Laboratories, Ciba-Geigy Japan Ltd., 10-66 Miyuki-cho, Takarazuka 665, Japan.
The Journal of Biological Chemistry
|March 28, 1997
Summary
Cathepsin K antisense oligodeoxynucleotides (S-ODN) significantly reduced osteoclast bone resorption by inhibiting cathepsin K protein levels. This suggests cathepsin K is crucial for osteoclast activity in bone resorption.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Biology
Background:
- Cathepsin K is a cysteine protease highly expressed in osteoclasts.
- Osteoclasts are responsible for bone resorption, a process critical for bone remodeling and disease.
Purpose of the Study:
- To investigate the role of cathepsin K in osteoclastic bone resorption.
- To evaluate the efficacy of cathepsin K antisense phosphothiorate oligodeoxynucleotide (S-ODN) in inhibiting bone resorption.
Main Methods:
- Rabbit osteoclasts were cultured on dentine slices.
- Treatment with cathepsin K antisense S-ODN, sense S-ODN, mismatch S-ODN, or E-64.
- Quantification of osteoclast pit formation and cathepsin K protein levels.
Main Results:
- Antisense S-ODN treatment significantly decreased cathepsin K protein levels in osteoclasts.
- Osteoclastic pit formation was inhibited by antisense S-ODN in a concentration-dependent manner.
- The inhibitory effect of antisense S-ODN on pit formation was comparable to that of the cysteine protease inhibitor E-64.
Conclusions:
- Cathepsin K plays a crucial role in osteoclastic bone resorption.
- Antisense S-ODN is an effective inhibitor of cathepsin K activity and osteoclast function.
- Targeting cathepsin K may represent a therapeutic strategy for bone resorption disorders.